Skip to main content
. 2016 Nov 30;2016:5409653. doi: 10.1155/2016/5409653

Table 1.

CD predisposing HLA-DQ frequencies in CD patients and controls and general genetic risk.

Genotypes DQB1∗02 status CD% (n = 237) Control (n = 237) pCD/control General risk
1 : 100
DQ2.5/DQ2.5 (β2/β2) 6.33% (15) 0.42% (1) 0.0004 1 : 7
DQ2.5/DQ2.2 (β2/β2) 25.31% (60) 2.53% (6) <0.0001 1 : 10
DQ2.5/DQ8 (β2/x) 8.86% (21) 1.68% (4) 0.0007 1 : 19
DQ2.5 (β2/x) trans 10.54% (25) 2.11% (5) 0.0002 1 : 20
(β2/x) cis 32.91% (78) 11% (26) <0.0001 1 : 30
DQ2.2/DQ8 (β2/x) 6.33% (15) 2.53% (6) 0.0718 1 : 40
DQ2.2/DQ2.2 (β2/β2) 0.84% (2) 2.11% (5) 0.4496 1 : 251
DQ8 3.8% (9) 10.97% (26) 0.0043 1 : 289
DQ2.2 (β2/x) 2.53% (6) 13.92% (33) 0.0001 1 : 550
DQ8/α5 0.42% (1) 4.22% (10) 0.0108 1 : 1005
α5 1.3% (3) 20.25% (48) <0.0001 1 : 1594
Absent 0.84% (2) 25.31% (60) <0.0001 1 : 3014
α8 0.0% (0) 2.95% (7) 0.0149 ND

ND: risk not determined; CD: celiac disease; β2 refers to DQB1∗02; α5 refers to DQA1∗05; α8 refers to DQA1∗03:01; x denotes not determined allele; β2/β2 refers to DQB1∗02 homozygosis; β2/x refers to DQB1∗02 heterozygosis; p value.